Literature DB >> 4144064

Antihypertensive therapy with adrenergic beta-receptor blockers and vasodilators.

W Aenishänslin, J Pestalozzi-Kerpel, U C Dubach, P R Imhof, M Turri.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 4144064     DOI： 10.1007/bf00561142

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  11 in total

1.  Pharmacological aspects of oxprenolol.

Authors:  H Brunner; P R Hedwall; R Maier; M Meier
Journal:  Postgrad Med J       Date:  1970-11       Impact factor: 2.401

2.  The effect of selective cardiac adrenergic beta-blockade on the hypotensive effect of hydrallazine.

Authors:  A S Dahr; C F George; C T Dollery
Journal:  Experientia       Date:  1971-05-15

3.  Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.

Authors:  E Gilmore; J Weil; C Chidsey
Journal:  N Engl J Med       Date:  1970-03-05       Impact factor: 91.245

4.  Chronic beta adrenergic blockade in arterial hypertension. Hemodynamic influences of dihydralazine and dynamic exercise and clinical effects of combined treatment.

Authors:  R Sannerstedt; J Stenberg; A Vedin; C Wilhelmsson; L Werkö
Journal:  Am J Cardiol       Date:  1972-05       Impact factor: 2.778

5.  Combined dihydralazine and propranolol in the treatment of hypertension.

Authors:  M Katila; M H Frick
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1970-12

6.  Hemodynamic interference of alprenolol with dihydralazine in normal and hypertensive man.

Authors:  R Sannerstedt; J Stenberg; G Johnsson; L Werkö
Journal:  Am J Cardiol       Date:  1971-09       Impact factor: 2.778

7.  [Effects of 1-4-dihydrazinophthalazine on arterial pressure and heart rate, before and after administration of beta-blocking drugs].

Authors:  S Campus; A Rappelli; F Fabris; I Mathis
Journal:  Boll Soc Ital Biol Sper       Date:  1967-12-31

8.  [Effects of acute and chronic diminution of cardiac output on blood pressure in early hypertention. Hemodynamic alterations after beta-receptor blockade].

Authors:  M Molzahn; T Dissmann; R Gotzen; F W Lohmann
Journal:  Klin Wochenschr       Date:  1971-04-15

9.  Influence of adrenergic beta-receptor blockade on the acute cardiovascular effects of hydralazine.

Authors:  H Brunner; P R Hedwall; M Meier
Journal:  Br J Pharmacol Chemother       Date:  1967-05

10.  Treatment of hypertension with propranolol.

Authors:  B N Prichard; P M Gillam
Journal:  Br Med J       Date:  1969-01-04
View more
  7 in total

Review 1.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

2.  Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension.

Authors:  P A Majid; M K Meeran; M E Benaim; B Sharma; S H Taylor
Journal:  Br Heart J       Date:  1974-06

Review 3.  Beta-adrenergic receptor blocking drugs in hypertension.

Authors:  F O Simpson
Journal:  Drugs       Date:  1974       Impact factor: 9.546

4.  Altered renin release and propranolol potentiation of vasodilatory drug hypotension.

Authors:  W A Pettinger; K Keeton
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

5.  Hydrallazine or phentolamine as adjuncts to beta-adrenoceptor blockade/thiazide therapy in hypertension.

Authors:  J F Winchester; D M Ward; J H McKillop; A C Kennedy
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

6.  Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.

Authors:  M Motolese; G Muiesan; A Colombi
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

Review 7.  Uses of beta-adrenoceptor blocking drugs.

Authors:  B N Prichard; D G McDevitt; R G Shanks
Journal:  J R Coll Physicians Lond       Date:  1976-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.